Literature DB >> 32110832

Simultaneous quantitation of glycyrrhetic acid and puerarin in plasma using ultra flow liquid chromatography tandem mass spectrometry and application in a pharmacokinetics study in healthy and alcoholic liver injury rats.

Chenxiao Shan1, Qi Yuan1, Xiaobing Cui1, Chuan Chai1, Sheng Yu1, Hongmei Wen1, Xi Huang2.   

Abstract

A rapid, sensitive, and accurate ultra flow liquid chromatography tandem mass spectrometry (UFLC-MS/MS ) method was developed and validated for simultaneous quantitation of glycyrrhetic acid and puerarin in plasma derived from healthy and alcoholic liver injury rats. Plasma samples from healthy and model rats were deproteinated with methanol using liquiritin as an internal standard. Chromatography separation was performed by a Waters BEH (ethylene-bridged hybrid) C18 column (2.1 × 50 mm; 1.7 μm) using a gradient elution from acetonitrile and water (containing 0.1% formic acid) and at a flow rate of 0.4 mL/min. Quantitation was performed on a Triple Quad 4500 tandem mass spectrometer coupled with an electrospray ionization source in negative multiple reaction monitoring mode. Specificity, carryover, dilution integrity, recovery, linearity, precision and accuracy, matrix effect, and stability were within acceptable limits. The newly established method was successfully applied to a pharmacokinetics study to investigate glycyrrhetic acid and puerarin in healthy and alcoholic liver injury rats.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  UFLC-MS/MS; alcoholic liver injury rat; glycyrrhetic acid; pharmacokinetics; puerarin

Mesh:

Substances:

Year:  2020        PMID: 32110832     DOI: 10.1002/bmc.4818

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  1 in total

1.  Identification of absorbed compounds of Xiao Yao San Jia Wei and pharmacokinetic study in depressed rats by force swimming stress.

Authors:  Chenxiao Shan; Jia Li; Bo Sun; Runze Zhou; Min Xu; Qiulong Zhao; Ping Ren; Hongmei Wen; Xi Huang
Journal:  RSC Adv       Date:  2022-02-04       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.